Neena M. Patil serves as the Executive Vice President and Chief Legal Officer at Jazz Pharmaceuticals plc, a global biopharmaceutical company focused on developing and commercializing life-changing medicines. In her role, Patil oversees the company's legal affairs, including corporate governance, compliance, intellectual property, and litigation. Her strategic leadership has been instrumental in guiding Jazz Pharmaceuticals through complex legal landscapes and ensuring the company's continued growth and success. Before joining Jazz Pharmaceuticals, Patil held several high-profile positions in the legal and healthcare sectors. She previously served as the Senior Vice President, General Counsel, and Secretary at Allergan, where she played a key role in the company's mergers and acquisitions, including the $63 billion acquisition by AbbVie in 2020. Patil's extensive experience also includes serving as Vice President and General Counsel at Amylin Pharmaceuticals and as a partner at the law firm Latham & Watkins LLP, where she specialized in corporate and securities law. Her diverse background has equipped her with the skills and insights necessary to navigate the intricate challenges faced by a leading biopharmaceutical company like Jazz Pharmaceuticals. Patil's contributions to Jazz Pharmaceuticals extend beyond her legal expertise. She is a member of the company's Executive Committee, where she helps shape the overall strategic direction of the organization. Her commitment to fostering a culture of integrity and compliance has been recognized both within and outside the company. Patil's leadership has been crucial in maintaining Jazz Pharmaceuticals' reputation as a trusted partner in the healthcare industry, dedicated to improving patient outcomes and advancing medical innovation.